SCHEMBL13638286

SCHEMBL13638286

C=C1CC(Nc2nccc(-c3ccc(-c4ccncc4)s3)n2)CC(C)(C)N1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 2/20 0.35
CDK4 P11802 7/20 0.35
CDK1 P06493 5/20 0.35
CCNB1 P14635 5/20 0.35
CCNA2 P20248 5/20 0.35
CCND1 P24385 5/20 0.35
CDK2 P24941 5/20 0.35
CCNA1 P78396 5/20 0.35
IKBKB O14920 3/20 0.34
MAPK8 P45983 5/20 0.33
MAPK9 P45984 3/20 0.33
MAPK10 P53779 3/20 0.33
CCNE1 P24864 1/20 0.33
CCND3 P30281 1/20 0.33
CDK6 Q00534 1/20 0.33
AURKA O14965 1/20 0.32
TTK P33981 1/20 0.32
AURKB Q96GD4 1/20 0.32
INCENP Q9NQS7 1/20 0.32
KDR P35968 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13638302 0.90 IKBKB (0.46) CDK4CDK1CCNB1CCNA2CCND1
SCHEMBL14612849 0.90 IKBKB (0.35) CDK4CDK1CCNB1CCNA2CCND1
SCHEMBL13638501 0.90 HDAC8 (0.41) ROCK2CDK1CCNB1CCNA2CDK2
SCHEMBL14612807 0.89 IKBKB (0.44) ROCK2CDK4CDK1CCNB1CCNA2
SCHEMBL14612804 0.89 MKNK1 (0.39) IKBKBMKNK1HDAC8
SCHEMBL13638514 0.88 IKBKB (0.33) CDK4CDK1CCNB1CCNA2CCND1
SCHEMBL14612851 0.87 CDK5 (0.37) ROCK2CDK4CDK1CCNB1CCNA2
SCHEMBL13638428 0.86 CDK4 (0.42) CDK4CDK1CCNB1CCNA2CCND1
SCHEMBL14612876 0.86 IKBKB (0.45) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL13638420 0.86 KDM4E (0.38) CDK4CDK1CCNB1CCNA2CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615562-B2 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents NOVARTIS AG (CH) 2009-11-10 US disclosed